Skyline Ventures

Skyline Ventures

Skyline Ventures

Follow us
Alexa global traffic share
Latest investments Show all
$85,400,000
Venture capital (Series E)
Sutro Biopharma
$70,000,000
Post-IPO equity
Dicerna Pharma
Team Size
1–10
Employees
Geographical Focus
Past year's investments

Skyline Ventures participated in fewer than 3 rounds over the past year

Latest rounds
  • Sutro Biopharma: Venture capital (Series E) ($85.4M)
  • Dicerna Pharma: Post-IPO equity ($70M)
  • Proteon Therapeutics: Venture capital (Series D) ($45M)